LAVA Therapeutics N.V. (LVTX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Cash from Operations | -4.87M | -13.75M | -11.64M | -1.41M | -8.63M | -8.21M | -843K | -11.02M | -7.11M | -13.06M | -8.34M | 33.78M | -14.34M | -9.72M | -7.63M | -7.43M | -8.18M | -8.54M | -4.5M | -10.01M |
| Operating CF Margin % | - | - | - | -28.16% | - | - | -12.06% | -3123.15% | -13409.43% | -254.23% | -680.96% | 1279.73% | -93.99% | -2076.92% | -746.38% | -697.37% | -390.41% | -790.28% | -449.9% | -567.36% |
| Operating CF Growth % | 43.59% | -67.38% | -1281.38% | 87.26% | -21.43% | 37.13% | 89.89% | -132.63% | 50.45% | -34.41% | -9.27% | 554.46% | -75.38% | -13.88% | -69.55% | 25.73% | - | -286% | -83% | - |
| Net Income | -7.19M | -8.64M | -3.48M | -4.22M | -12.2M | -8.3M | -608K | -6.41M | -8.79M | -12.6M | -13.87M | -15M | 983K | -8.03M | -10.5M | -8.22M | -6.93M | -7.43M | -19.72M | -5.31M |
| Depreciation & Amortization | 3K | 8K | 107K | -220K | 212K | 120K | 144K | 352K | 318K | 295K | 313K | 271K | 168K | 174K | 168K | 144K | 151K | 134K | 129K | 411.99K |
| Stock-Based Compensation | 393K | 441K | 540K | 590K | 720K | 820K | 1.09M | 0 | 924K | 1.56M | 1.63M | 0 | 841K | 378K | 2.23M | 977K | 1.26M | 1.02M | 641K | 283.23K |
| Deferred Taxes | 0 | 0 | 0 | 240K | -96K | -85K | -69K | 0 | -51K | -97K | -71K | 0 | -46K | -75K | -60K | 0 | 0 | -32K | -24K | -52.79K |
| Other Non-Cash Items | 2.12M | -581K | -5.17M | -1.59M | 1.43M | -392K | -759K | 2.13M | -1.11M | -661K | 476K | 4.22M | -2.62M | -3.1M | -359K | -1.78M | -2.81M | 773K | 150K | -144.26K |
| Working Capital Changes | -200K | -4.98M | -3.64M | 3.79M | 1.3M | -377K | -646K | -7.1M | 1.6M | -1.56M | 3.19M | 44.29M | -13.67M | 937K | 886K | 1.45M | 147K | -3M | 14.32M | -5.2M |
| Change in Receivables | 0 | 0 | 0 | 0 | 399K | -254K | 758K | -579.8K | 3.26M | -2.4M | 1.29M | 46.86M | -50.06M | -106K | 0 | 1.04M | -974K | -89K | 821K | -1.23M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.13M |
| Change in Payables | 201K | -219K | -1.25M | 49K | -1.46M | 672K | -934K | -5.13M | 4.42M | 1.95M | -916K | -3.44M | 4.87M | 133K | 105K | 0 | 0 | 895K | 337K | -1.42M |
| Cash from Investing | 27.7M | -2.5M | 15.16M | 10.97M | 447K | 363K | 694K | -8.53M | -16.85M | 224K | 7.68M | -3.63M | 6.58M | 3.53M | 3.37M | -821K | -42.55M | -8K | -166K | -114.91K |
| Capital Expenditures | 0 | 0 | 0 | 0 | -23K | 23K | -23K | 7.76K | -6K | -224K | -500K | -266.33K | 25K | -24K | -323K | -168K | -422K | -8K | -166K | -114.91K |
| CapEx % of Revenue | - | - | - | - | - | - | 0.33% | 2.2% | 11.32% | 4.36% | 40.85% | 10.09% | 0.16% | 5.13% | 31.6% | 15.76% | 20.14% | 0.74% | 16.6% | 6.51% |
| Acquisitions | 0 | 293.92K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 5K | -10.92K | 0 | -6K | 2K | 3K | 89K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -653K | -42.13M | 0 | 0 | 0 |
| Cash from Financing | 0 | 0 | 0 | -206K | -368K | 16K | 8K | 393.63K | -482K | -157K | -97K | -7.05K | -7K | 36K | 270K | -161K | 216K | 2.44M | 148.66M | 1.08M |
| Debt Issued (Net) | 0 | 0 | 0 | -206K | -370K | -12K | -8K | -347.32K | -482K | -157K | -97K | 113.43K | -7K | 21K | 270K | -162K | 216K | 202K | 84K | 519.87K |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 2.38K | 0 | 0 | 0 | 0 | 0 | 0 | 425 | 0 | 0 | 0 | 0 | 0 | 1000K | 1000K | 363.94K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.17M | -279.62K |
| Other Financing | 0 | 0 | 0 | 0 | -382 | 28K | 16K | 740.95K | 0 | 0 | 0 | -120.91K | 0 | 15K | 0 | 1K | 0 | -1K | 0 | 0 |
| Net Change in Cash | 23.28M | -13.29M | 4.66M | 8.05M | -8.12M | -8.1M | -1.04M | -18.43M | -24.94M | -13M | 271K | 36M | -11.54M | -9.86M | -5.15M | -9.5M | -52.31M | -5.57M | 142.43M | -8.95M |
| Free Cash Flow | -4.87M | -13.75M | -11.64M | -1.41M | -8.65M | -8.19M | -866K | -11.02M | -7.11M | -13.29M | -8.84M | 33.52M | -14.32M | -9.74M | -7.95M | -7.6M | -8.6M | -8.54M | -4.67M | -10.12M |
| FCF Margin % | - | - | - | -28.16% | - | - | -12.39% | -3120.95% | -13420.75% | -258.59% | -721.81% | 1269.64% | -93.83% | -2082.05% | -777.98% | -713.13% | -410.55% | -791.02% | -466.5% | -573.88% |
| FCF Growth % | 43.74% | -67.86% | -1244.69% | 87.25% | -21.65% | 38.36% | 90.2% | -132.87% | 50.32% | -36.38% | -11.12% | 540.92% | -66.48% | -14.06% | -70.44% | 24.91% | - | -287.44% | -79.98% | - |
| FCF per Share | -0.18 | -0.51 | -0.43 | -0.05 | -0.32 | -0.31 | -0.03 | -0.41 | -0.27 | -0.51 | -0.34 | 1.27 | -0.54 | -0.38 | -0.31 | -0.29 | -0.33 | -0.33 | -0.18 | -0.40 |
| FCF Conversion (FCF/Net Income) | 0.68x | 1.59x | 3.35x | 0.35x | 0.70x | 0.99x | 1.39x | 1.70x | 0.80x | 1.03x | 0.60x | -2.27x | -15.32x | 1.20x | 0.78x | 0.90x | 1.18x | 1.06x | 0.23x | 3.77x |
| Interest Paid | 0 | 0 | 0 | -246K | 38K | 0 | 0 | 0 | 38K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |